Discover 150+

Leading Biopharma Players in South Korea’s Rapidly Growing Ecosystem

Introduction

South Korea has emerged as one of Asia’s most dynamic biopharma hubs, home to 150+ innovative companies spanning biologics, cell & gene therapy, CROs, and CDMOs. From global leaders like Samsung Biologics and Celltrion to fast-rising biotech innovators, the ecosystem is rapidly expanding across R&D, manufacturing, and commercialization.

This curated landscape provides a comprehensive overview of key players shaping the future of biopharmaceutical development in South Korea—highlighting opportunities for partnerships, outsourcing, and market entry.

Whether you're looking to identify potential partners or clients, this dataset offers valuable insights into one of Asia’s most competitive and fast-evolving markets.

South Korea - Biopharma

JOIN BIOLOGICS MANUFACTURING KOREA 2026!

14 Years of Excellence: South Korea’s Biggest Biologics Manufacturing Conference

📍 Songdo Convensia, Incheon, South Korea 📆 17 - 18 September 2026

CO-LOCATED WITH

AGENDA AT GLANCE

Day 0 | 16 September 2026

SITE TOUR

PRE-CONFERENCE WORKSHOP

Day 1 | 17 September 2026
Day 1 | 17 September 2026
Day 2 | 18 September 2026
Day 2 | 18 September 2026
Leadership Panel Discussion
Scaling Biologics & CGT in East Asia: Innovation, Manufacturing Challenges & Collaborative Strategies
Automation and Bioprocessing 4.0
Building Intelligent, Connected Facilities

Leadership Panel Discussion:

Redefining ADC Therapeutics: Addressing Toxicity, Enhancing Efficacy, and the Rise of Dual Payload Designs

Morning Tea Break, Exhibition Viewing & 1-1 Attendees Networking
Upstream Processing
Optimizing Cell Culture and Yield
Scaling Manufacturing for Cell & Gene Therapy: Optimizing Smart Manufacturing and Automation

Tech Transfer, Scale-Up & CMC Excellence Bridging Development and Commercialisation

Scaling Up ADC Production:

Overcoming Challenges in Bioconjugation and Purification

Lunch Break, Exhibition Viewing & 1-1 Attendees Networking
Downstream Processing Enhancing Purification and Recovery
CAR-T & CAR-NK Therapies Case Studies: Next-Gen Cell Therapy & Preclinical Innovation

Aseptic Fill-Finish & Packaging

Optimizing ADC Target Selection and Engineering for Maximum Efficacy

Afternoon Tea Break, Exhibition Viewing & 1-1 Attendees Networking
Quality & Analytics Ensuring Precision and Compliance
Gene Editing and CRISPR: Case Studies in Therapeutic Applications

Supply Chain Optimization & Smart Facility Design and Capacity Planning

Advancing Payloads and Linker Technologies for Next-Generation ADCs

End of Conference

➜ EXHIBIT YOUR SOLUTIONS
➜ APPLY TO SPEAK

Share With Your Network